{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:09:06Z","timestamp":1793059746446,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajog.2021.06.052","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:35:12Z","timestamp":1623458112000},"page":"515.e1-515.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Anti-M\u00fcllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals"],"prefix":"10.1016","volume":"225","author":[{"given":"Eduardo","family":"Hariton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia N.","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataki C.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Hershlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-3234","authenticated-orcid":false,"given":"Sharon F.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.06.052_bib1","first-page":"1","article-title":"Births: final data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2021.06.052_bib2","first-page":"1","article-title":"Mean age of mothers is on the rise: United States, 2000-2014","volume":"232","author":"Mathews","year":"2016","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2021.06.052_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/aogs.13335","article-title":"The dawn of a new ice age: social egg freezing","volume":"97","author":"Jones","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.06.052_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40834-018-0064-y","article-title":"Return of fertility after discontinuation of contraception: a systematic review and meta-analysis","volume":"3","author":"Girum","year":"2018","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.ajog.2021.06.052_bib5","first-page":"393","article-title":"The correlations of anti-M\u00fcllerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women","volume":"8","author":"Barbakadze","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antiM\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.06.052_bib8","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum anti-M\u00fcllerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2021.06.052_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A\u00a0systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2021.06.052_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/uog.11226","article-title":"Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles","volume":"41","author":"Deb","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.052_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.06.052_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antiM\u00fcllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"Van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.052_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.fertnstert.2017.02.105","article-title":"Demographic, lifestyle, and other factors in relation to antiM\u00fcllerian hormone levels in mostly late premenopausal women","volume":"107","author":"Jung","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-M\u00fcllerian hormone in a large population-based study","volume":"98","author":"D\u00f3lleman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.06.052_bib17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum M\u00fcllerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antiM\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"AntiM\u00fcllerian hormone levels decrease in women using combined contraception independently of administration route","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.rbmo.2019.10.004","article-title":"Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives","volume":"40","author":"Landersoe","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2021.06.052_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases","volume":"25","author":"Van Den Berg","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.06.052_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2014.05.026","article-title":"AntiM\u00fcllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception","volume":"102","author":"Johnson","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.06.052_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: A comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2021.06.052_bib24","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/humrep\/dev197","article-title":"Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan","volume":"30","author":"Birch Petersen","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.06.052_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13625187.2019.1702158","article-title":"Ovarian reserve markers in women using various hormonal contraceptives","volume":"25","author":"Landersoe","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2021.06.052_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.10114","article-title":"Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-M\u00fcllerian hormone and small antral follicle count using three-dimensional ultrasound","volume":"39","author":"Deb","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.052_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/09513590.2017.1320376","article-title":"Prediction value of anti-M\u00fcllerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment","volume":"33","author":"Bas-Lando","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2021.06.052_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/AOG.0000000000003066","article-title":"Concordance of fingerstick and venipuncture sampling for fertility hormones","volume":"133","author":"Burke","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.052_bib30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/humrep\/des194","article-title":"Quantification of anti-M\u00fcllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve","volume":"27","author":"McDade","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.06.052_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/09513590.2017.1306848","article-title":"Anti-M\u00fcllerian hormone does not predict time to pregnancy: results of a prospective cohort study","volume":"33","author":"Depmann","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2021.06.052_bib32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2021.06.052_bib33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.clinbiochem.2016.08.005","article-title":"Performance characteristics of the Access AMH assay for the quantitative determination of anti-M\u00fcllerian hormone (AMH) levels on the Access\u2217 family of automated immunoassay systems","volume":"49","author":"Demirdjian","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ajog.2021.06.052_bib34","first-page":"94","article-title":"Evidence of profound ovarian suppression on combined hormonal contraception resulting in dramatically different ovarian reserve testing and oocyte retrieval outcomes: case report and review of the literature","volume":"1","author":"Fox","year":"2020","journal-title":"Fertil Steril Rep"},{"key":"10.1016\/j.ajog.2021.06.052_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-M\u00fcllerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.06.052_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.13415","article-title":"Age-stratified thresholds of anti-M\u00fcllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold","volume":"87","author":"Quinn","year":"2017","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821006852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821006852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:34:52Z","timestamp":1757590492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821006852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0002937821006852"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.052","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}